Trial To Examine Google Glass As Autism Treatment
the Psychiatry Advisor take:
Google Glass could soon be used a tool to help children with autism spectrum disorder as a clinical trial run by researchers at Stanford University is under way
Catalin Voss, Dennis Wall, PhD and Nick Haber, PhD, are working together to see if an app for Google Glass created by Voss, which can tell if the person you are looking at, by recognizing facial expressions is happy, sad, etc., can work with kids who have autism.
While the trio has tested the software in a lab with 40 children, they are beginning a clinical trial with nearly 100 kids at home.
“First, we had to make sure that a six-year-old would actually wear this,” Wall told Wired. “We’ve been able to show that. But we’ve also been able to see change in these kids, at least in the lab.” He added that the software also records what the child does while wearing Google Glass which a clinician can review.
Wall is also working on diagnosing autism at an earlier age using machine learning algorithms to analyze data on the behavior of autistic kids to look for the signals of the disorder.
The Stanford project is not the first to look at the potential of Google Glass in treating autism. Brain Power, a tech startup in Cambridge, Mass., is developing applications to be used with Google Glass as an autism therapy.
App being test by researchers recognizes facial expression and helps kids with autism determine what person they are looking at is feeling.
In his first year at Stanford, Catalin Voss helped build an app for Google Glass that could recognize emotions. If you put on Google's computerized eyewear and looked at others in front of you, the software could tell you — based on their facial expressions — if they were happy, sad, surprised, or disgusted.
But at Stanford, Voss has bigger ambitions. He's now working with Dennis Wall, a professor in the university's school of medicine, to hone this technology into something useful for children diagnosed with autism. This was one of Voss's original aims when he built Sension, but that didn't fit the broader prospects of the business. So he spun off the idea as a project inside the medical school.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Panel Recommends Earlier Body Weight Monitoring in Use of Mood Stabilizers
- Nondaily Cigarette Use Increasing Among Individuals With Mental Health, Substance Use Disorders
- Cesarean Delivery, Early Childhood Antibiotic Use Not Associated With Risk for ADHD
- Uncertainty as a Form of Violence: Current Immigration Policy and Crisis
- FDA Gets Tough on Juul, Other Electronic Cigarette Makers